IL-7 splicing variant IL-7δ5 induces human breast cancer cell proliferation via activation of PI3K/Akt pathway

Biochemical and Biophysical Research Communications

Volumn 422, Issue 4, 2012, Pages 727-731

  Pan, Deshun ^a   Liu, Bing ^a   Jin, Xiaobao ^a   Zhu, Jiayong ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Cyclin D1; Human breast cancer; IL 7 variant; IL 7 5; P27 kip1; PI3K Akt; Proliferation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN D1; INTERLEUKIN 7; PROTEIN KINASE B; PROTEIN P27; PROTEIN VARIANT;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLICING DEFECT; UPREGULATION;

ALTERNATIVE SPLICING; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; HUMANS; INTERLEUKIN-7; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84862271396     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.070     Document Type: Article

References (25)

1. Appasamy P.M. Biological and clinical implications of interleukin-7 and lymphopoiesis. Cytokines Cell Mol. Ther. 1999, 5:25-39.
2. Schluns K.S., Kieper W.C., Jameson S.C., Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 2000, 1:426-432.
3. Maeurer M.J., Walter W., Martin D., Zitvogel L., Elder E., Storkus W., Lotze M.T. Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes. Scand. J. Immunol. 1997, 45:182-192.
4. Trinder P., Seitzer U., Gerdes J., Seliger B., Maeurer M. Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer. Int. J. Oncol. 1999, 14:23-31.
5. Cosenza L., Gorgun G., Urbano A., Foss F. Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines. Cell. Signal. 2002, 14:317-325.
6. Palmer M.J., Mahajan V.S., Trajman L.C., Irvine D.J., Lauffenburger D.A., Chen J. Interleukin-7 receptor signaling network: an integrated systems perspective. Cell. Mol. Immunol. 2008, 5:79-89.
7. Yamanaka K., Clark R., Rich B., Dowgiert R., Hirahara K., Hurwitz D., Shibata M., Mirchandani N., Jones D.A., Goddard D.S., Eapen S., Mizutani H., Kupper T.S. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma. Blood 2006, 107:2440-2445.
8. Gonzalez-Garcia S., Garcia-Peydro M., Martin-Gayo E., Ballestar E., Esteller M., Bornstein R., de la Pompa J.L., Ferrando A.A., Toribio M.L. CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia. J. Exp. Med. 2009, 206:779-791.
9. Silva A., Laranjeira A.B., Martins L.R., Cardoso B.A., Demengeot J., Yunes J.A., Seddon B., Barata J.T. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias. Cancer Res. 2011, 71:4780-4789.
10. Ming J., Jiang G., Zhang Q., Qiu X., Wang E. Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer. Cancer Immunol. Immun. 2011, 61:79-88.
11. Stamm S., Ben-Ari S., Rafalska I., Tang Y., Zhang Z., Toiber D., Thanaraj T.A., Soreq H. Function of alternative splicing. Gene 2005, 344:1-20.
12. Matlin A.J., Clark F., Smith C.W. Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol. 2005, 6:386-398.
13. Vudattu N.K., Magalhaes I., Hoehn H., Pan D., Maeurer M.J. Expression analysis and functional activity of interleukin-7 splice variants. Genes Immun. 2009, 10:132-140.
14. Garcia-Blanco M.A. Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing. J. Clin. Invest. 2003, 112:474-480.
15. Tsytsikov V.N., Yurovsky V.V., Atamas S.P., Alms W.J., White B. Identification and characterization of two alternative splice variants of human interleukin-2. J. Biol. Chem. 1996, 271:23055-23060.
16. Atamas S.P., Choi J., Yurovsky V.V., White B. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. J. Immunol. 1996, 156:435-441.
17. Takakuwa T., Nomura S., Matsuzuka F., Inoue H., Aozasa K. Expression of interleukin-7 and its receptor in thyroid lymphoma. Lab. Invest. 2000, 80:1483-1490.
18. Al-Rawi M.A., Rmali K., Mansel R.E., Jiang W.G. Interleukin 7 induces the growth of breast cancer cells through a wortmannin-sensitive pathway. Br. J. Surg. 2004, 91:61-68.
19. Alao J.P. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 2007, 6:24.
20. Belletti B., Nicoloso M.S., Schiappacassi M., Chimienti E., Berton S., Lovat F., Colombatti A., Baldassarre G. P27(kip1) functional regulation in human cancer: a potential target for therapeutic designs. Curr. Med. Chem. 2005, 12:1589-1605.
21. Tokunaga E., Oki E., Egashira A., Sadanaga N., Morita M., Kakeji Y., Maehara Y. Deregulation of the Akt pathway in human cancer. Curr. Cancer Drug Targets 2008, 8:27-36.
22. Kroemer R.T., Kroncke R., Gerdes J., Richards W.G. Comparison of the 3D models of four different human IL-7 isoforms with human and murine IL-7. Protein Eng. 1998, 11:31-40.
23. O'Neill L.A. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat. Rev. Drug Discovery 2006, 5:549-563.
24. Barata J.T., Silva A., Brandao J.G., Nadler L.M., Cardoso A.A., Boussiotis V.A. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J. Exp. Med. 2004, 200:659-669.
25. Wofford J.A., Wieman H.L., Jacobs S.R., Zhao Y., Rathmell J.C. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 2008, 111:2101-2111.